NOT KNOWN FACTUAL STATEMENTS ABOUT SODIUM PENTOBARBITAL

Contraindicated (1)pentobarbital will reduce the extent or effect of lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with strong CYP3A4 inducers can result in diminished serum concentrations and loss of antimalarial efficacyRoutine forming: Barbiturates could be routine forming. Tolerance, ps